Liraglutide effective in hard-to-treat T2DM

For type 2 patients injecting insulin several times daily, adding liraglutide can improve glycaemic control and reduce weight, say Swedish researchers.

Compared with placebo, patients randomised to the GLP-1 receptor agonist had a reduction in HbA1C of 16.9mmol/mol (1.5%) after 24 weeks of treatment.

These patients managed to lose an average of 3.8kg in weight, compared with no weight loss in the placebo